bioMérieux
Jennifer Zinn is a seasoned executive with extensive experience in global clinical operations and commercial strategy within the diagnostics and pharmaceutical industries. Currently serving as Executive Vice President for Global Clinical Operations at bioMérieux since October 2022, Jennifer oversees a workforce of 3000 employees dedicated to marketing, sales, and service. Prior roles include President of Clinical Operations for North America at Siemens Healthineers and Senior Vice President at Roche, where Jennifer led diverse teams and managed significant P&L responsibilities. A proven leader in marketing and training development, Jennifer has driven strategic initiatives and transformations that enhanced operational effectiveness and revenue growth. Jennifer holds a Bachelor’s Degree in Opera Performance from the University of Delaware.
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.